Evry (France) and Berlin (Germany) – 07 September, 2015 Global Bioenergies has joined aireg – Aviation Initiative for Renewable Energy in Germany e.V. – . The French industrial biology company,…Read More
Evry (France) – 1 September, 2015 Global Bioenergies today announces that John Pierce has been appointed as the new Chairman of its board of directors. John Pierce is an American…Read More
The isobutene process was first developed by Global Bioenergies using glucose derived from cereals such as wheat or corn. Early in 2015, the company announced that the process was compatible…Read More
Global Bioenergies (Alternext Paris: ALGBE) announces that its Bio-Isobutene process has reached 70% of the commercial yield at R&D scale. The targeted commercial yield is 3.84 tons of low-cost, industrial-grade…Read More
Global Bioenergies (Alternext Paris: ALGBE) today announces that its Bio-Isobutene process, first developed with glucose as a resource, is now adapted for the use of sucrose, the main component of…Read More
Invest Securities initiates coverage of Global Bioenergies’ stock (Alternext Paris: ALGBE) with a €50.6 objective. Invest Securities, a French Investment Bank, has specialized in small- and mid-cap and already covers over…Read More
Global Bioenergies today announced the publication of its registration document for the year to 31 December 2014.
Global Bioenergies (Alternext Paris : ALGBE) today announced the publication of its registration document for the year to 31 December 2014. On 5 June, Global Bioenergies submitted its registration document,…Read More